RadFollow
Sign in
Guideline Current ESGAR 2016

ESGAR 2016 Rectal Cancer MRI Staging

ESGAR consensus for rectal cancer MRI. Reports T-stage, mesorectal fascia (CRM) status, extramural vascular invasion (EMVI), and nodal disease to guide neoadjuvant therapy decisions.

Updated Jul 5, 2026
Applies to
  • Biopsy-proven rectal adenocarcinoma undergoing MRI staging
Classification
  • T stage T1
  • T stage T2
  • T stage T3
  • T stage T4
Exclusions

None listed

Interactive

Decision tree

Enter a finding to compute a recommendation without leaving the page.

Recommendation builder

Select the ESGAR risk category derived from mrT-stage, CRM, EMVI, and nodal status.

FAQ

Frequently asked

Does this guideline apply to oncology patients?

No — patients with known malignancy fall outside the scope unless the guideline states otherwise. Follow oncologic surveillance protocols instead.